About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Implementation & Impact >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >

Data Strategy, Analytics & AI >
Transform life sciences with AI-driven data strategies for impactful insights across the product lifecycle.

AI at Putnam

Data strategy

Integrated Advanced Analytics
AI at Putnam

Learn about our data strategy and analytics services for pharmaceutical companies in the life science industry.

Learn more
Join Putnam
Insights

Contact

Identifying micro-moments and how to leverage them

0 mins read

20 September 2022

Insights

More insights.

See all insights

Jump to a slide with the slide dots.

Thomas Leahy

Why Real-World External Control Arms Are Gaining Ground in Health Technology Assessment

Discover how real-world external control arms (RW-ECAs) provide robust comparative evidence for HTA submissions when RCTs are impractical or unethical

Yemi Oluboyede

Unlocking Patient Insights in HEOR Through Netnography: A Scalable Qualitative Research Method

In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets

Mariah Hanley

AI as the Input, Not the Answer: When Human Strategy Still Leads